Showing results (1191-1200 of 1,562) with videos related to

Sort By:
Pageof 157
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 20, 2015
Genome-Based Infection Tracking Reveals Dynamics of Clostridium difficile Transmission and Disease RecurrenceNitin Kumar, Fabio Miyajima, Miao He, et al.
Microbial Genomics|June 10, 2021
Functional analysis of colonization factor antigen I positive enterotoxigenic Escherichia coli identifies genes implicated in survival in water and host colonizationMoataz Abd El Ghany, Lars Barquist, Simon Clare, et al.
Mbio|October 10, 2019
A Genome-Wide Knockout Screen in Human Macrophages Identified Host Factors Modulating Salmonella InfectionAmy T Y Yeung, Yoon Ha Choi, Amy H Y Lee, et al.
Neuroscience Letters|May 19, 2009
A preliminary study of functional connectivity in comorbid adolescent depressionKathryn R Cullen, Dylan G Gee, Bonnie Klimes-Dougan, et al.
The Journal of Experimental Medicine|July 2, 2017
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cellsMohammad Rashidian, Jessica R Ingram, Michael Dougan, et al.
Nature Genetics|November 11, 2014
Identification of enterotoxigenic Escherichia coli (ETEC) clades with long-term global distributionAstrid von Mentzer, Thomas R Connor, Lothar H Wieler, et al.
Journal of Infection in Developing Countries|September 11, 2009
Antibodies to the Vi capsule of Salmonella Typhi in the serum of typhoid patients and healthy control subjects from a typhoid endemic regionDeborah House, Vo A Ho, To S Diep, et al.
Vaccine|April 7, 2007
Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humansS Khan, S Chatfield, R Stratford, et al.
Wellcome Open Research|November 3, 2020
A blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilitiesSushmita Sridhar, Sally Forrest, Iain Kean, et al.
Science Translational Medicine|May 20, 2021
cIAP1/2 antagonism eliminates MHC class I-negative tumors through T cell-dependent reprogramming of mononuclear phagocytesKevin Roehle, Li Qiang, Katherine S Ventre, et al.
Pageof 157